Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 257 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| HSD11B1L | ENSG00000167733 | 0.00 | 0.00 | 0 | 0 |
| SLCO1A2 | ENSG00000084453 | 0.00 | 0.00 | 0 | 0 |
| TXNDC16 | ENSG00000087301 | 0.00 | 0.00 | 0 | 0 |
| SLC16A6 | ENSG00000108932 | 0.00 | 0.00 | 0 | 0 |
| OXNAD1 | ENSG00000154814 | 0.00 | 0.18 | 0 | 1 |
| CYB5R2 | ENSG00000166394 | 0.00 | 0.00 | 0 | 0 |
| ADAM28 | ENSG00000042980 | 0.00 | 0.12 | 0 | 1 |
| LMTK2 | ENSG00000164715 | 0.26 | 0.00 | 2 | 0 |
| MAPK4 | ENSG00000141639 | 0.00 | 0.00 | 0 | 0 |
| GPI | ENSG00000105220 | 0.00 | 0.00 | 0 | 0 |
| INPP5B | ENSG00000204084 | 0.00 | 0.00 | 0 | 0 |
| FBLN2 | ENSG00000163520 | 0.00 | 0.00 | 0 | 0 |
| SLC24A5 | ENSG00000188467 | 0.00 | 0.00 | 0 | 0 |
| ITGA2 | ENSG00000164171 | 0.00 | 0.00 | 0 | 0 |
| ITGA6 | ENSG00000091409 | 0.26 | 0.00 | 1 | 0 |
| S1PR2 | ENSG00000267534 | 0.00 | 0.00 | 0 | 0 |
| SLC52A1 | ENSG00000132517 | 0.00 | 0.00 | 0 | 0 |
| C16orf89 | ENSG00000153446 | 0.00 | 0.00 | 0 | 0 |
| SLC17A4 | ENSG00000146039 | 0.00 | 0.00 | 0 | 0 |
| NCSTN | ENSG00000162736 | 0.51 | 0.00 | 3 | 0 |
|
Showing page 257 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.